Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 703

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 703
---
 Seller’s underlying business decision to proceed with or effect the Sale Transaction, or the
relative merits of the Sale Transaction as compared to any alternative business strategies or transactions that might be available to Seller or in which Seller might engage. This opinion is limited to and addresses only the fairness, from a
financial point of view, as of the date hereof, to Seller of the Consideration proposed to be paid to Seller pursuant to the terms of the Agreement. We have not been asked to, nor do we express any view on, and our opinion does not address, any
other term or aspect of the Agreement or the Sale Transaction, including, without limitation, the structure or form of the Sale Transaction, or any other agreements or arrangements contemplated by the Agreement or entered into in connection with or
otherwise contemplated by the Sale Transaction, including, without limitation, the fairness of the Sale Transaction or any other term or aspect of the Sale Transaction to, or any consideration to be received in connection therewith by, or the impact
of the Sale Transaction on, the holders of any class of securities, creditors or other constituencies of

C-2

Seller or any other party. In addition, we express no view or opinion as to the fairness (financial or otherwise) of the amount, nature or any other aspect of any compensation to be paid or
payable to any of the officers, directors or employees of Seller or any other party, or class of such persons in connection with the Sale Transaction, whether relative to the Consideration to be paid to Seller pursuant to the terms of the Agreement
or otherwise. Our opinion is necessarily based on financial, economic, monetary, currency, market and other conditions and circumstances as in effect on, and the information made available to us as of, the date hereof, and we do not have any
obligation or responsibility to update, revise or reaffirm this opinion based on circumstances, developments or events occurring after the date hereof. Our opinion does not constitute a recommendation to any stockholder of Seller as to whether or
how such stockholder should vote or otherwise act with respect to the Sale Transaction or any other matter.

Our financial advisory services and the
opinion expressed herein are provided for the information and assistance of the Board of Directors of Seller (in their capacity as directors and not in any other capacity) in connection with and for purposes of its consideration of the Sale
Transaction. This opinion has been authorized by the Leerink Partners LLC Fairness Opinion Review Committee.

Based upon and subject to the